FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria (Q28293514)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria |
scientific article |
Statements
FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria (English)
0 references
September 2008
0 references
13
0 references
9
0 references
993-1000
0 references